Overview

Empirico uses human genetics and large biological datasets to discover and develop new medicines, focusing on target discovery and collaborations. Its Precision Insights Platform analyzes genetic and health data from millions of individuals using curated data, custom models, and proprietary algorithms to generate and rank high-confidence therapeutic hypotheses. It differentiates itself by grounding drug targets in naturally occurring genetic variation and by pairing a large dataset with partner-driven experiments (e.g., AbCellera) to validate hypotheses. Its goal is to improve the success rate of drug development by identifying validated targets and translating them into medicines through collaborations.